FGF2 and ovarian neoplasm: FABP4 mRNA and protein levels were significantly induced in cultured endothelial cells by VEGF-A and bFGF (basic fibroblast growth factor) treatment [125,126,130], while angiogenesis, growth and metastasis in ovarian tumor xenografts were markedly inhibited by therapeutic siRNA delivery targeting mouse endothelial FABP4 [130].